1. Study on immunoassay site LAG3 in Alzheimer's disease.
- Author
-
MENG Lingyun, DUAN Ran, and CHEN Jing
- Subjects
- *
ALZHEIMER'S disease , *KILLER cells , *CELLULAR control mechanisms , *IMMUNOASSAY - Abstract
Objective: To investigate the role and significance of immunoassay locus LAG3 gene in Alzheimer's disease (AD). Methods: Based on the GEO (https://www. ncbi. nlm. nih. gov/geo/) in the database of AD patients, brain sequencing dataset GSE48350 and blood sequencing dataset GSE140829 were analyzed. The scores of immune cells in the brain tissue were obtained by using the CIBERSORT ratings and the expression of LAG3 was observed. Mouse hippocampal neuron cell line HT22 induced by human Aβ1-42 amyloid was used as the cell model of AD disease. The expression of LAG3 was detected by RT-PCR. GSEA analysis was used to explore pathways directly associated with LAG3 and the String site was used to build PPI networks, genes interacting with LAG3 were discovered, and the biological functions of these genes were analyzed by KEGG and GO. Results: There was a great difference between the constitute of immune cells in the brain tissue of AD patients and that of normal controls. The level of LAG3 expression in brain tissue and blood of AD patients were higher than that of normal controls, so as the cell model. Conclusion: The constitute of immune cells in AD disease brain tissue and normal person is different. The results in the brain tissue of AD patients of the higher percentage of inactive memory CD4+T cells and mononuclear cells, lower proportion of the activation of NK cells, and the more increased expression of immune examination site LAG3 may be associated with CD4 cells and the activation and regulation of immune cells. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF